[ sulge aken ]

Elulookirjeldus (CV)
1.Eesnimi Ello
2.Perekonnanimi Karelson
3.Töökoht Tartu Ülikool,
Biokeemia Instituut
4.Ametikoht dotsent
5.Sünniaeg 06.08.1946 (päev.kuu.aasta)
6.Haridus TÜ Arstiteaduskond, 1972.a.
TÜ Aspirantuur (biokeemia) 1977.a.
7.Teenistuskäik 1972-1977 vanemlaborant, TÜ Biokeemia kateeder ja Sekretoorsete Protsesside Biokeemia Laboratoorium
1978-1979 nooremteadur, TÜ Sekretoorsete Protsesside Biokeemia Laboratoorium
1979-1989 vanemõpetaja, TÜ Biokeemia kateeder
1989-2005 dotsent, TÜ Biokeemia Inst.
1994-1996 TÜ Meditsiinilise Biokeemia Õppetooli hoidja
8.Teaduskraad meditsiinikandidaat
meditsiinidoktor
9.Teaduskraadi välja
andnud asutus, aasta
Kõrgem Atestatsiooni Komisjon (Moskva), 1978
TÜ Arstiteaduskonna kraadinõukogu, 1999
10.Tunnustused Põhjamaade Minstrite Nõukogu Stipendiaat Turu Akadeemilises Ülikoolis (Soome), 1995
Rootsi Instituudi stipendiaat Stockholmi Ülikoolis 1998, 2000
Rootsi Kuningliku Akadeemia stipendiaat Stockholmi Ülikoolis,2002
Rahvusvahelise Wenner-Gren fondi stipendiaat Stockholmi Ülikoolis, 2003
Rootsi Dementsiafondi "DemensFonden" stipendiaat Stockholmi Ülikoolis ja Karolinska Instituudis, 2004
11.Teadusorganisatsiooniline
ja –administratiivne
tegevus
1979 -1996 Eesti biokeemia Seltsi Tartu osakonna sekretär
Rahvusvaliste konverentside orgkomiteede liige
Kahe rahvusvahelise eelretsenseeritava zurnaali referent
Mitmete bakalaureuse ja magistritööde retsensent
Rahvuvaheline koostöö Karolinska Instituudi Huddinge Ülikooli Kliiniku Geriaatria osakonnaga (Rootsi) ja Stockholmi Ülikooli Neurokeemia Osakonnaga (Rootsi)
12.Juhendamisel kaitstud
väitekirjad

Riina Mahlapuu, MSc, 2000, juh. Ülo Langel, Ello Karelson, Uno Mäeorg. Amüloid beta-peptiidide efektid aju signaalülekandes. Tartu Ülikool

Tanel Toomela, MSc, 1996, juh. Jaak Järv, Ello Karelson. Muskariinse retseptori agonisti anatgonistliku toime avaldumine ligandi kõrgel kontsentratsioonil. Tartu Ülikool

Andres Valkna, MSc, 1995, juh. Ello Karelson, Mihkel Zilmer. Roti hipokampuse adenülaaditsüklaasi regulatsioon neuropeptiid galaniini ja tema analoogidega. Tartu Ülikool

13.Teadustöö põhisuunad 1. Neuropeptiidide sh. amüloid-beeta peptiidide ja neuroprotektorite sh. östrogeenide ja isoflavonoidide molekulaarsed mehhanismid aju G-valk-vahendatud signaalradade tasandil normaalsel vananemisel ja neurodegeneratsiooni puhul
2. Aju ioon-pumbad neuropeptiidide, neurotoksiliste agensite ja neurodegeneratsiooni märklauana
3. Alzheimeri tõve molekulaarsed, sh. oksüdatiivsed mehhanismid postmortaalse inimaju tasandil
14.Jooksvad grandid Eesti Teadusfondi grant Nr. 5222 "Fütoöstrogeenide ja östrogeenide neuroprotektiivne mehhanism inimaju füsiloogilisel vananemisel ja neurodegeneratsiooni puhul (postmortem uuring)", 2002-2005
15.Teaduspublikatsioonid

Karelson E, Fernaeus S, Reis K, Bogdanovic N, Land T. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms. J Neurosci Res. 2005 Feb 1;79(3):368-74. PMID: 15614786

Mahlapuu R, Viht K, Balaspiri L, Bogdanovic N, Saar K, Soomets U, Land T, Zilmer M, Karelson E, Langel U. Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain. Brain Res Mol Brain Res. 2003 Sep 10; 117(1):73-82. PMID: 14499483

Roots K, Koks S, Kairane C, Salum T, Karelson E, Vasar E, Zilmer M. Na-pump kinetic properties are differently altered in the brain regions of the cholecystokinin(2)receptor-deficient mice. Ann N Y Acad Sci. 2003 Apr;986:644-645. PMID: 12763910

Jefremov V, Rakitin A, Mahlapuu R, Karelson E, Zilmer M, Bogdanovic N. Antioxidant mechanism of estrogens: relevance to modulation of hippocampal G-proteins in Alzheimer's disease. Neurobiol of Aging. 23(1):S334-S334 1239 Suppl.1, Jul-Aug 2002. ISSN: 0197-4580

Kairane C, Roots K, Uusma T, Bogdanovic N, Karelson E, Koks S, Zilmer M. Regulation of the frontocortical sodium pump by Na+ in Alzheimer's disease: difference from the age-matched control but similarity to the rat model. FEBS Lett. 2002 Nov 6;531(2):241-4 PMID: 12417319

Karelson E, Mahlapuu R, Zilmer M, Soomets U, Bogdanovic N, Langel U. Possible signaling by glutathione and its novel analogue through potent stimulation of frontocortical G-proteins in normal aging and in Alzheimer's disease. Ann N Y Acad Sci. 2002 Nov;973:537-40. PMID: 12485924

Bogdanovic N, Zilmer M, Zilmer K, Rehema A, Karelson E; The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex. Dement Geriatr Cogn Disord. 2001 Nov-Dec;12(6):364-70. PMID: 11598307

Karelson E, Bogdanovic N, Garlind A, Winblad B, Zilmer K, Kullisaar T, Vihalemm T, Kairane C, Zilmer M. The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defence. Neurochem Res. 2001 Apr;26(4):353-61. PMID: 11495345

Saar K, Mahlapuu R, Laidmäe E, Valkna A, Kahl U, Karelson E. Langel U. Characterization of a new chimeric ligand for galanin receptors:galanin(1-13)-[D-Trp32)]-neuropeptideY(25-36)amide. Regul Pept. 2001 Oct 15;102(1):15-9. PMID: 11600206

viimati muudetud: 16.08.2005

Curriculum Vitae (CV)
1.First Name Ello
2.Surname Karelson
3.Institution Deapartment of Biochemistry
Univesrity of Tartu
4.Position Associate Professor (docent)
5.Date of birth 06.08.1946 (day.month.year)
6.Education Faculty of Medicine, University of Tartu, 1972
University of Tartu, Postgraduate studentship (biochemistry),1977
7.Research and
professional experience
1972-1977 Senior Research Assistant, Department of Biochemistry and Laboratory of Biochemistry of Secretory Processes, University of Tartu
1978-1979 Junior Researcher, Laboratory of Biochemistry of Secretory Processes, University of Tartu
1979-1989 Senior Assistant (lecturer), Department of Biochemistry, University of Tartu
1989-2005 Associate Professor (docent),University of Tartu
1994-1996 Curator of Chair of Medical Bichemistry, University of Tartu
8.Academic degree Doctor of Philosphy (Candidate of Medicine)
Doctor of Medicinae
9.Dates and sites of
earning the degrees
Higher Atestation Commision (Moscow), 1978
Council of the Faculty of Medicinae,
University of Tartu
10.Honours/awards Scholar of Nordic Council of Ministers in Abo Academy University (Finland), 1995
Scholar of Swedish Institute in University of Stockholm, 1998, 2000
Scholar of Royal Swedish Academy of Sciences in University of Stockholm, 2002
Scholar of International Wenner-Gren Foundation in University of Stockholm, 2003
Scolar of Swedish "DemensFonden" in University of Stockholm and in Karolinska Institute, 2004
11.Research-administrative
experience
1979 -1996 Secretary of Estonian Biochemical Society (Section of Tartu)
The member of Organizing Committees of International Conferences
Reviewer of two international peer-reviewd journals
Reviewer of many Baccalaureate and Master thesis
International Collaboration with Geraitric Department of Huddinge University Hospital at Karolinska Institute (Sweden)
and Department of Neurochemistry at University of Stockholm
12.Supervised dissertations

Riina Mahlapuu, MSc, 2000, superv. Ülo Langel, Ello Karelson, Uno Mäeorg. Amüloid beta-peptiidide efektid aju signaalülekandes. Tartu Ülikool

Tanel Toomela, MSc, 1996, superv. Jaak Järv, Ello Karelson. Muskariinse retseptori agonisti anatgonistliku toime avaldumine ligandi kõrgel kontsentratsioonil. Tartu Ülikool

Andres Valkna, MSc, 1995, superv. Ello Karelson, Mihkel Zilmer. Roti hipokampuse adenülaaditsüklaasi regulatsioon neuropeptiid galaniini ja tema analoogidega. Tartu Ülikool

13.Current research program 1. Molecular mecanisms of neuropeptides, incl. amyloid-beta peptides, and neuroprotectors, incl. estrogens and isoflavonoids, at the level of brain G-protein-mediated signalling pathways in normal aging and in neurodegeneration
2. Brain ion-pumps as a target of neuropeptides, neurotoxic agents and neurodegeneration
3. Molecular (incl. oxidative) mechanisms of Alzheimer's disease at the level of postmortal human brain
14.Current grant funding Estonian Scientific Foundation Grant No. 5222 " Neuroprotective mechanism of phytoestrogens and estrogens in physiological aging of human brain and in neurodegeneration", 2002 -2005.
15.List of most important publications

Karelson E, Fernaeus S, Reis K, Bogdanovic N, Land T. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms. J Neurosci Res. 2005 Feb 1;79(3):368-74. PMID: 15614786

Mahlapuu R, Viht K, Balaspiri L, Bogdanovic N, Saar K, Soomets U, Land T, Zilmer M, Karelson E, Langel U. Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain. Brain Res Mol Brain Res. 2003 Sep 10; 117(1):73-82. PMID: 14499483

Roots K, Koks S, Kairane C, Salum T, Karelson E, Vasar E, Zilmer M. Na-pump kinetic properties are differently altered in the brain regions of the cholecystokinin(2)receptor-deficient mice. Ann N Y Acad Sci. 2003 Apr;986:644-645. PMID: 12763910

Jefremov V, Rakitin A, Mahlapuu R, Karelson E, Zilmer M, Bogdanovic N. Antioxidant mechanism of estrogens: relevance to modulation of hippocampal G-proteins in Alzheimer's disease. Neurobiol of Aging. 23(1):S334-S334 1239 Suppl.1, Jul-Aug 2002. ISSN: 0197-4580

Kairane C, Roots K, Uusma T, Bogdanovic N, Karelson E, Koks S, Zilmer M. Regulation of the frontocortical sodium pump by Na+ in Alzheimer's disease: difference from the age-matched control but similarity to the rat model. FEBS Lett. 2002 Nov 6;531(2):241-4 PMID: 12417319

Karelson E, Mahlapuu R, Zilmer M, Soomets U, Bogdanovic N, Langel U. Possible signaling by glutathione and its novel analogue through potent stimulation of frontocortical G-proteins in normal aging and in Alzheimer's disease. Ann N Y Acad Sci. 2002 Nov;973:537-40. PMID: 12485924

Bogdanovic N, Zilmer M, Zilmer K, Rehema A, Karelson E; The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex. Dement Geriatr Cogn Disord. 2001 Nov-Dec;12(6):364-70. PMID: 11598307

Karelson E, Bogdanovic N, Garlind A, Winblad B, Zilmer K, Kullisaar T, Vihalemm T, Kairane C, Zilmer M. The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defence. Neurochem Res. 2001 Apr;26(4):353-61. PMID: 11495345

Saar K, Mahlapuu R, Laidmäe E, Valkna A, Kahl U, Karelson E. Langel U. Characterization of a new chimeric ligand for galanin receptors:galanin(1-13)-[D-Trp32)]-neuropeptideY(25-36)amide. Regul Pept. 2001 Oct 15;102(1):15-9. PMID: 11600206

last updated: 16.08.2005

[ sulge aken ]